Hangzhou Thinheal Pharma-Tech Co.,Ltd

With over 20 years of experience in the peptide industry, we offer integrated capabilities spanning R&D, pilot-scale development, and cGMP-compliant production, with an annual capacity ranging from milligrams to 4,000 kilograms. Leveraging both solid-phase and liquid-phase peptide synthesis technologies, we provide one-stop API and CRDMO solutions, all backed by comprehensive cGMP and ISO quality assurance systems. Holds a US DMF for tirzepatide (filed 2024).

Directory assessment: Hangzhou Thinheal Pharma-Tech Co.,Ltd is listed as a CDMO in the peptide supply chain, shipping to 中国 from China (Hangzhou). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 3 sources for reference. This supplier has a medium confidence score — verification signals are present, but the listing is newer or less documented; perform standard due diligence before engaging.